302 related articles for article (PubMed ID: 21224499)
21. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
Efrati S; Berman S; Chachashvili A; Cohen N; Siman-Tov Y; Averbukh Z; Weissgarten J
Nephrology (Carlton); 2009 Apr; 14(2):189-97. PubMed ID: 19143945
[TBL] [Abstract][Full Text] [Related]
22. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis.
Celiński K; Madro A; Prozorow-Król B; Korolczuk A; Cichoz-Lach H; Słomka M; Korobowicz E
Med Sci Monit; 2009 Jan; 15(1):BR21-9. PubMed ID: 19114961
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
[TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone reduces the inflammatory response in a model of vascular injury in rats.
Rinaldi B; Pieri L; Donniacuo M; Cappetta D; Capuano A; Domenici L; Carnuccio R; Romagnoli P; Filippelli A; Rossi F
Shock; 2009 Dec; 32(6):638-44. PubMed ID: 19333142
[TBL] [Abstract][Full Text] [Related]
25. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
Berruyer C; Pouyet L; Millet V; Martin FM; LeGoffic A; Canonici A; Garcia S; Bagnis C; Naquet P; Galland F
J Exp Med; 2006 Dec; 203(13):2817-27. PubMed ID: 17145956
[TBL] [Abstract][Full Text] [Related]
26. Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.
Linard C; Grémy O; Benderitter M
J Pharmacol Exp Ther; 2008 Mar; 324(3):911-20. PubMed ID: 18077625
[TBL] [Abstract][Full Text] [Related]
27. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
28. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
Zhang M; Deng C; Zheng J; Xia J; Sheng D
Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
[TBL] [Abstract][Full Text] [Related]
29. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.
Clemente TR; Dos Santos AN; Sturaro JN; Gotardo EM; de Oliveira CC; Acedo SC; Caria CR; Pedrazzoli J; Ribeiro ML; Gambero A
Scand J Gastroenterol; 2012 Sep; 47(8-9):943-50. PubMed ID: 22630819
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
Xiao J; Leung JC; Chan LY; Guo H; Lai KN
Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
[TBL] [Abstract][Full Text] [Related]
32. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction.
Ponferrada A; Caso JR; Alou L; Colón A; Sevillano D; Moro MA; Lizasoain I; Menchén P; Gómez-Lus ML; Lorenzo P; Cos E; Leza JC; Menchén L
Gastroenterology; 2007 May; 132(5):1791-803. PubMed ID: 17484875
[TBL] [Abstract][Full Text] [Related]
33. Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes.
Lee TI; Kao YH; Chen YC; Pan NH; Lin YK; Chen YJ
Clin Sci (Lond); 2011 Oct; 121(7):305-12. PubMed ID: 21501116
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone reduces secondary brain damage after experimental brain trauma by PPAR-γ-independent mechanisms.
Thal SC; Heinemann M; Luh C; Pieter D; Werner C; Engelhard K
J Neurotrauma; 2011 Jun; 28(6):983-93. PubMed ID: 21501066
[TBL] [Abstract][Full Text] [Related]
36. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
[TBL] [Abstract][Full Text] [Related]
37. Altered PPARgamma expression and activation after transient focal ischemia in rats.
Victor NA; Wanderi EW; Gamboa J; Zhao X; Aronowski J; Deininger K; Lust WD; Landreth GE; Sundararajan S
Eur J Neurosci; 2006 Sep; 24(6):1653-63. PubMed ID: 17004929
[TBL] [Abstract][Full Text] [Related]
38. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
[TBL] [Abstract][Full Text] [Related]
39. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Shah YM; Morimura K; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
[TBL] [Abstract][Full Text] [Related]
40. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
Churi SB; Abdel-Aleem OS; Tumber KK; Scuderi-Porter H; Taylor BK
J Pain; 2008 Jul; 9(7):639-49. PubMed ID: 18387855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
